Table 2.
MDRO infection prevalence by comorbidity and medical device (N = 323)
| Variable category | MDRO-positive (n) | Prevalence (%) |
|---|---|---|
| Comorbidities | ||
| Seizure | 1 | 100.0 |
| LRTI | 4 | 66.6 |
| CKD with hemodialysis | 5 | 62.5 |
| Rheumatoid arthritis | 1 | 50.0 |
| CVA | 1 | 50.0 |
| BPH | 2 | 40.0 |
| T2DM | 48 | 32.2 |
| Hypothyroidism | 3 | 27.2 |
| Hypertension | 37 | 25.1 |
| Asthma | 1 | 25.0 |
| Medical devices | ||
| Non-invasive ventilation | 29 | 27.1 |
| Ryle's tube | 28 | 25.6 |
| Foley's catheterization | 66 | 23.7 |
| Central line | 17 | 23.6 |
%, Percentage; BPH, benign prostatic hyperplasia; CKD, chronic kidney disease; CVA, cerebrovascular accident; LRTI, lower respiratory tract infection; MDRO, multidrug-resistant organism; n, number of patients in a subgroup; N, total number of patients; T2DM, type 2 diabetes mellitus